Report an error

Spotted something inaccurate in “Phase 1 Trial: All-Oral Maintenance After RIC Transplant Yields 77% 2-Year Survival in Poor-Risk MDS/AML”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.